Can Gene Therapy Stop the Progression of Osteoarthritis?

Can Gene Therapy Stop the Progression of Osteoarthritis?

Kolon Life Sciences has attained approval in South Korea for a first-in-class cell-mediated gene therapy designed to treat osteoarthritis through regeneration of cartilage. “Kolon has said injection of Invossa has been shown in Phase III trials in Korea to ease the symptoms of about 84% of patients – while 88% of U.S. patients treated with Read more about Can Gene Therapy Stop the Progression of Osteoarthritis?[…]

Stem Cell Joint Injections: Anecdotally Patients Improve… but Western Medicine Still Struggling to Prove It

Stem Cell Joint Injections: Anecdotally Patients Improve… but Western Medicine Still Struggling to Prove It Stem Cell Injections: Emerging Option for Joint Pain Relief https://health.clevelandclinic.org/2017/07/stem-cell-injections-emerging-option-for-joint-pain-relief/

Arthro CEO Takes a Haircut Or Why Your CEO Should Not Bet Your Sales Team

Arthro CEO Takes a Haircut Or Why Your CEO Should Not Bet Your Sales Team

  Yesterday was a big day for Arthroventions as we celebrated our first sale by cutting my hair. I am so proud of our team and their hard work over the last year and a half. Launching a medical device company has been one of the hardest and most challenging endeavors we have all undertaken. Read more about Arthro CEO Takes a Haircut Or Why Your CEO Should Not Bet Your Sales Team[…]

Arthroventions Reflects on the NSF’s I-Corps Program and Customer Discovery

Arthroventions Reflects on the NSF’s I-Corps Program and Customer Discovery

On Thursday, Arthroventions reflected on customer discovery and validated learning as part of the National Science Foundation’s (NSF) Innovation Corps (I-Corps™) program, hosted by the Colorado Clinical and Translational Science Institute (CCTSI). The I-Corps program provides real-world, hands-on, immersive learning about what it takes to successfully commercialize products and services that customers want. During the Read more about Arthroventions Reflects on the NSF’s I-Corps Program and Customer Discovery[…]